Inspiratory pressure support (IPS) decreases the work of breathing in patients with hyperinflation secondary to airways obstruction when weaning from mechanical ventilation.'0 Non-invasive assisted ventilation has been shown to reduce breathlessness during acute ventilatory failure resulting from COPD. " These patients have increased loads on the respiratory muscles, particularly during exercise, inducing extreme breathlessness. We hypothesised that the application of non-invasive IPS during exercise may reduce breathlessness and improve exercise tolerance by reducing the load on the respiratory muscles. This hypothesis was tested by measuring the effects of non-invasive IPS by face mask on the tolerance to treadmill exercise in eight patients with stable severe COPD. Walks with IPS were compared with those with oxygen and CPAP.
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Methods
Eight men with stable COPD who complained of disabling breathlessness on exertion were recruited from the chest clinic (age range 60-74 years, mean (SD) FEV, 0 73 (02) 1).
All patients underwent a period of familiarisation before data collection. This involved several visits to the laboratory where treadmill walks, with and without breathing equipment, were performed so that the patients became completely familiar with the use of the face masks, CPAP, IPS, the Borg scale, and the treadmill. During this training period a comfortable walking speed was found for each patient matching as closely as possible their usual walking speed. Once this had been established, all subsequent walks were performed at this speed. Patients were asked to walk on the treadmill until their perceived rating of When patients were familiar with the laboratory routine, data were collected on three separate days. The study consisted of walking with a different mode of respiratory support on each day: IPS, CPAP, or oxygen at 2 1/min. These were compared with two other treadmill walks on each occasion: a baseline walk (walking freely on the treadmill) and a control walk using a "sham" gas delivery system -breathing air from an unlabelled cylinder at 2 1/min. All patients experienced all conditions. The tests were performed in random order and each walk was preceded by at least 30 minutes rest. No more than three days elapsed between study visits. No patients had had a recent exacerbation of their disease or a change in their medication over the study period.
Non-invasive inspiratory pressure support was applied using a pressure cycled ventilator ("NIPPY", Thomas Respiratory Systems, London, UK) with the inspiratory pressure set for patient comfort (range 12-15 cm H20). All breaths were patient triggered (threshold 0 5 cm H20) and applied to the patients' airway via a full face mask held in position by a Velcro head strap. To apply CPAP a "BiPAP" ventilatory support system (Respironics Inc, Murrysville, Pennsylvania, USA) was used with the inspiratory and expiratory positive airway pressure dials set to achieve 6 cm H20, maintaining a positive pressure throughout the respiratory cycle, via a full face mask. The oxygen and control (air) walks were performed with a standard oxygen mask (Intersurgical Ltd, Wokingham, UK) with a gas flow of 2 During exercise transcutaneous partial pressure of oxygen (TcPo2) and carbon dioxide (TcPco2) using a combined electrode (Radiometer Ltd, Copenhagen, Denmark) were monitored continuously, as were oxygen saturation (Sao2) and heart rate by pulse oximetry (Ohmeda Ltd). These were recorded at one minute intervals during exercise. At one minute intervals patients were also asked their perceived breathlessness rating which they communicated by pointing to a number or phrase on the Borg scale set in large type on a sheet in front of them. The treadmill was stopped when the patient had reached level 5 (severe) on the Borg scale.
On cessation of exercise the distance achieved and duration of exercise were recorded, together with a Borg score for leg fatigue.
DATA ANALYSIS All data were analysed using a statistical computer software package (Minitab Inc, Pennsylvania, USA). The percentage change in median walking distance achieved with respiratory intervention was compared with baseline and control walks for each visit using the Wilcoxon signed rank test for non-parametric data.
Results
All patients completed all parts of the study. Table 1 shows the baseline measurements of the patients. No patient stopped walking due to leg fatigue, only stopping when the perceived breathlessness rating had reached level 5 (severe). Table 2 shows the walking distance achieved in each case. Figure 1 shows the effect of IPS on exercise tolerance compared with the On each occasion the control walk (using the sham system) was compared with the baseline walk. There was no difference in walking distance achieved between the baseline and control walks. No significant change in walking distance occurred with either oxygen at 2 1/min or CPAP at 6 cm H20.
Dyspnoea ratings during the walks with IPS were lower than those during control walks. Figure 2 shows the perceived sensation of breathlessness (Borg scale) plotted against time (minutes) during IPS assisted walking compared with the control walk for each patient.
At the end of the control walk patients showed a mean fall in oxygen saturation of 6% (range 1-11%). anisms of breathlessness, and may facilitate the mobility and rehabilitation of these severely disabled people.
